“…Sex differences have been demonstrated in the incidence and progression of, as well as medication effectiveness in, several neuropsychiatric disorders, including Parkinson's disease, schizophrenia, obsessive-compulsive disorder, and drug abuse (eg Seeman, 1996;Bogetto et al, 1999;Cyr et al, 2002;Wieck et al, 2003;Lynch et al, 2002;Lynch, 2006). Dysfunction of brain dopamine (DA) systems, particularly the D2-like superfamily of DA receptors, has been associated with these conditions (Cross et al, 1981;Guttman and Seeman, 1985;Volkow et al, 1993;Hesse et al, 2005).…”